多发性硬化症随访的医学法律考虑:增强或非增强MRI?

Q2 Medicine
M Salducci, V Martines, M S Simonelli
{"title":"多发性硬化症随访的医学法律考虑:增强或非增强MRI?","authors":"M Salducci, V Martines, M S Simonelli","doi":"10.7417/CT.2025.5281","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Scientific literature supports that, in cases of multiple sclerosis, follow-up for clinically stable patients can be performed with an non-enhanced magnetic resonance examination (MRI). One of the reasons for applying the contrast medium protocol, even in cronic patients, is the fear of legal disputes.</p><p><strong>Objectives: </strong>Our objective is to to analyze the risks of performing a non-enhanced MRI control test. In multiple sclerosis (MS) cronic patients, the control test monitors the evolution of the disease. The MRI show the evolution of the disease represented by the appearance of new lesions or the extension in size of already known lesions.</p><p><strong>Results: </strong>The only situation where the use of contrast medium can provide further information not deducible from the baseline examination is the reactivation of one or more lesions already present without the appearance of new lesions. This situation is extremely rare. Furthermore, the interval between one check-up to the next is time that isn't significant with respect to the evolution of a chronic disease even if a therapy is modified or started late.</p><p><strong>Conclusion: </strong>The fear of incurring legal disputes related to the failure to administer contrast medium has no reason to influence the professional choices of radiologists.</p>","PeriodicalId":50686,"journal":{"name":"Clinica Terapeutica","volume":"176 5","pages":"675-677"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Medico legal consideration about the follow-up in multiple sclerosis: enhanced or non enhanced MRI?\",\"authors\":\"M Salducci, V Martines, M S Simonelli\",\"doi\":\"10.7417/CT.2025.5281\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Scientific literature supports that, in cases of multiple sclerosis, follow-up for clinically stable patients can be performed with an non-enhanced magnetic resonance examination (MRI). One of the reasons for applying the contrast medium protocol, even in cronic patients, is the fear of legal disputes.</p><p><strong>Objectives: </strong>Our objective is to to analyze the risks of performing a non-enhanced MRI control test. In multiple sclerosis (MS) cronic patients, the control test monitors the evolution of the disease. The MRI show the evolution of the disease represented by the appearance of new lesions or the extension in size of already known lesions.</p><p><strong>Results: </strong>The only situation where the use of contrast medium can provide further information not deducible from the baseline examination is the reactivation of one or more lesions already present without the appearance of new lesions. This situation is extremely rare. Furthermore, the interval between one check-up to the next is time that isn't significant with respect to the evolution of a chronic disease even if a therapy is modified or started late.</p><p><strong>Conclusion: </strong>The fear of incurring legal disputes related to the failure to administer contrast medium has no reason to influence the professional choices of radiologists.</p>\",\"PeriodicalId\":50686,\"journal\":{\"name\":\"Clinica Terapeutica\",\"volume\":\"176 5\",\"pages\":\"675-677\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica Terapeutica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7417/CT.2025.5281\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Terapeutica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7417/CT.2025.5281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景:科学文献支持,在多发性硬化症病例中,临床稳定的患者可以通过非增强磁共振检查(MRI)进行随访。使用造影剂方案的原因之一,即使是在慢性患者中,是对法律纠纷的恐惧。目的:我们的目的是分析进行非增强MRI对照试验的风险。在多发性硬化症(MS)慢性患者中,对照试验监测疾病的演变。MRI显示疾病的演变,表现为新病变的出现或已知病变的扩大。结果:使用造影剂可以提供基线检查无法推断的进一步信息的唯一情况是一个或多个已经存在的病变重新激活,而没有出现新的病变。这种情况极为罕见。此外,一次检查与下一次检查之间的间隔时间对于慢性疾病的发展并不重要,即使治疗被修改或开始较晚。结论:由于担心造影剂使用失败而引起法律纠纷,没有理由影响放射科医师的专业选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Medico legal consideration about the follow-up in multiple sclerosis: enhanced or non enhanced MRI?

Background: Scientific literature supports that, in cases of multiple sclerosis, follow-up for clinically stable patients can be performed with an non-enhanced magnetic resonance examination (MRI). One of the reasons for applying the contrast medium protocol, even in cronic patients, is the fear of legal disputes.

Objectives: Our objective is to to analyze the risks of performing a non-enhanced MRI control test. In multiple sclerosis (MS) cronic patients, the control test monitors the evolution of the disease. The MRI show the evolution of the disease represented by the appearance of new lesions or the extension in size of already known lesions.

Results: The only situation where the use of contrast medium can provide further information not deducible from the baseline examination is the reactivation of one or more lesions already present without the appearance of new lesions. This situation is extremely rare. Furthermore, the interval between one check-up to the next is time that isn't significant with respect to the evolution of a chronic disease even if a therapy is modified or started late.

Conclusion: The fear of incurring legal disputes related to the failure to administer contrast medium has no reason to influence the professional choices of radiologists.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinica Terapeutica
Clinica Terapeutica PHARMACOLOGY & PHARMACY-
CiteScore
2.50
自引率
0.00%
发文量
124
审稿时长
6-12 weeks
期刊介绍: La Clinica Terapeutica è una rivista di Clinica e Terapia in Medicina e Chirurgia, fondata nel 1951 dal Prof. Mariano Messini (1901-1980), Direttore dell''Istituto di Idrologia Medica dell''Università di Roma “La Sapienza”. La rivista è pubblicata come “periodico bimestrale” dalla Società Editrice Universo, casa editrice fondata nel 1945 dal Comm. Luigi Pellino. La Clinica Terapeutica è indicizzata su MEDLINE, INDEX MEDICUS, EMBASE/Excerpta Medica.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信